E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/29/2009 in the Prospect News Investment Grade Daily.

S&P rates Mead Johnson notes BBB

Standard & Poor's said it assigned a BBB corporate credit rating to Mead Johnson Nutrition Co. and BBB- ratings to its proposed $1.5 billion senior unsecured notes to be issued in three parts with five-, 10- and 30-year maturities.

The outlook is stable.

Proceeds will be used to repay $1.7 billion of related-party notes held by majority shareholder Bristol-Myers Squibb Co.

Ratings reflect the company's leading position in the infant formula market, its good brand recognition, strong geographical diversification and good cash flow generation, S&P said.

These factors are partially offset by a relatively narrow business focus and moderate debt levels, the agency said.

Bristol-Myers Squibb Co. (A+/stable/A-1) has an 83% equity stake in Mead Johnson following a partial sale of the company through an initial public offering in February. Despite the significant equity ownership, S&P said it treats Mead Johnson as a standalone company and do not factor any implicit support in the rating.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.